ICER (USD/QALY) | Percent coverage of screening (not taking into account EoS approach) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Percent coverage of HPV vaccine (not taking into account EoS approach) | % coverage | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90 | 100 |
10 | 1860b | − 11100a | − 3480a | − 2540a | − 2140a | − 1890a | − 1720a | − 1580a | − 1450a | − 1340a | |
20 | 410b | 1670b | 6730c | − 15430a | − 5080a | − 3420a | − 2700a | − 2280a | − 1990a | − 1770a | |
30 | 170b | 670b | 1510b | 3230c | 9470c | − 30430a | − 7260a | − 4470a | − 3330a | − 2690a | |
40 | 60b | 370b | 780b | 1350b | 2250b | 3940c | 8580c | 114020c | − 12250a | − 6170a | |
50 | 10b | 230b | 490b | 810b | 1210b | 1750b | 2520b | 3800c | 6410c | 15380c | |
60 | − 30a | 140b | 330b | 550b | 790b | 1080b | 1420b | 1850b | 2410b | 3200c | |
70 | − 50a | 90b | 240b | 400b | 570b | 750b | 950b | 1180b | 1430b | 1720b | |
80 | − 70a | 50b | 170b | 300b | 430b | 560b | 700b | 840b | 990b | 1140b | |
90 | − 80a | 20b | 120b | 230b | 330b | 430b | 540b | 640b | 740b | 830b | |
100 | − 90a | 0b | 90b | 170b | 260b | 340b | 430b | 500b | 570b | 640b |